Parkside Financial Bank & Trust’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693 Buy
+285
New +$696 ﹤0.01% 2530
2023
Q1
Sell
-111
Closed -$299 2079
2022
Q4
$299 Buy
+111
New +$324 ﹤0.01% 1945
2022
Q2
Sell
-169
Closed -$1K 1910
2022
Q1
$1K Sell
169
-138
-45% -$1.07K ﹤0.01% 1746
2021
Q4
$3K Buy
307
+202
+192% +$2.15K ﹤0.01% 1516
2021
Q3
$1K Buy
+105
New +$1.63K ﹤0.01% 1690

Other funds holding ORGO

Parkside Financial Bank & Trust's ORGO Position: Q2 2026 in Review

Parkside Financial Bank & Trust opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 285 shares worth $693. The stake represents ﹤0.01% of the portfolio and ranks #2530 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in ORGO as recently as Q4 2022.

Parkside Financial Bank & Trust first reported a position in ORGO in Q3 2021 and has held it in 5 quarters since. The position peaked at $3K in Q4 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Parkside Financial Bank & Trust held 285 shares of Organogenesis Holdings worth $693 as of Q2 2026.
  • Organogenesis Holdings was a new Parkside Financial Bank & Trust position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2530 holding.
  • Parkside Financial Bank & Trust first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Organogenesis Holdings position peaked at $3K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.